Laboratory of Operational Hygiene became part of the Tentamus Pharma Group

Beginning of June, VelaLabs Austria, part of the Tentamus Pharma division, acquired the pharmaceutical test laboratory Laboratorium für Betriebshygiene GmbH (“LABH”), based in Vienna Austria. “The sustainable merger with VelaLabs and, in the background, the umbrella of the Tentamus Pharma Mehr

Tentamus Group acquires majority stake in Megsan Labs

Tentamus Group today announced that it has acquired a majority stake in the leading analytical testing services company to pharmaceutical companies, Megsan Labs (in Hyderabad, India). The acquisition is part of Tentamus’ plan to broaden its portfolio of services that Mehr

Neue Grenzwerte für Vitamin D und Erucasäure in Säuglingsanfangsnahrung und Folgenahrung

Am 23.05.2019 hat die Europäische Komission in der Delegierten Verordnung (EU) 2016/127 neue Höchstgehalte für Vitamin D und Erucasäure in Säuglingsanfangsnahrung und Folgenahrung festgelegt. Die Änderungen treten am 12.06.2019 (20 Tage nach Veröffentlichung) in Kraft. Die Höchstgehalte von Vitamin D Mehr

New limits for vitamin D and erucic acid in infant formula and follow-on formula

On 23 May 2019, the European Commission set new maximum levels for vitamin D and erucic acid in infant formula and follow-on formula in the Delegate Regulation (EU) 2016/127. The changes will come into force on 12.06.2019 (20 days after Mehr

Draft Guidance for Industry: Mitigation Strategies to Protect Food Against Intentional Adulteration – IA Rule Next Compliance date is July 26, 2019

This draft guidance is being distributed for comment purposes only; submit comments by 07/05/2019 (https://www.regulations.gov/document?D=FDA-2018-D-1398-0025). FSMA’s Mitigation Strategies to Protect Food Against Intentional Adulteration (IA Rule) requires both domestic and foreign companies that are required to register with the FDA Mehr

FDA Draft Guidance – Initiation of Voluntary Recalls

This draft guidance is being distributed for comment purposes only; submit comments by 06/24/2019 (https://www.regulations.gov/…). Under 21 CFR 7, subpart C, the FDA lists guidance on policy, procedures, and industry responsibilities for recalls and product correction for voluntary recalls of Mehr